Shares of medical device company Integra LifeSciences (NASDAQ:IART) fell 5.7% in the afternoon session after the stock's negative momentum continued as the company reported weak third-quarter results ...
Truist lowered the firm’s price target on Integra LifeSciences (IART) to $13 from $15 and keeps a Hold rating on the shares. The firm notes it was surprised to see a Q3 revenue miss following multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results